Diagnosis & Disease Information

Oncology CME

Crizotinib Provides Clinically Meaningful Antitumor Activity in Patients with Previously Treated ALK-Positive Advanced Non-Small-Cell Lung Cancer

August 17, 2012

This CME activity from ASCO 2012 reviews crizotinib in patients with ALK-positive non-small cell lung cancer.

Oncology CME

Carfilzomib, Lenalidomide, Low-Dose Dexamethasone Provides Rapid, Deep Responses in Patients with Newly Diagnosed Multiple Myeloma

August 13, 2012

This CME activity from ASCO 2012 reviews carfilzomib, lenalidomide, and low-dose dexamethasone in patients with newly diagnosed multiple myeloma.

Oncology CME

Pomalidomide Active in Patients with Multiple Myeloma Refractory to Lenalidomide, Bortezomib—or Both—and in Transplant Failures

August 13, 2012

This CME activity reviews pomalidomide in combination with low-dose dexamethasone in patients with multiple myeloma refractory to lenalidomide, bortezomib, or both.

Next post in Oncology CME

Interim Analysis Shows Abiraterone Acetate Significantly Improves Radiographic Progression-Free Survival in Chemo-Naïve Metastatic Castration-Resistant Prostate Cancer